|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910465222303321 |
|
|
Titolo |
Dyslipidemia [[electronic resource] /] / Ragavendra R. Baliga, Christopher P. Cannon |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford ; ; New York, : Oxford University Press, 2012 |
|
|
|
|
|
|
|
ISBN |
|
1-283-57735-6 |
9786613889805 |
0-19-978037-4 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (152 p.) |
|
|
|
|
|
|
Collana |
|
Oxford American Cardiology Library |
|
|
|
|
|
|
Altri autori (Persone) |
|
BaligaR. R |
CannonChristopher P |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Lipids - Metabolism - Disorders - Treatment |
Atherosclerosis - Treatment |
Coronary heart disease |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Contents; Contributors; 1 LDL Cholesterol; 2 HDL Cholesterol; 3 Non-HDL Cholesterol; 4 Use of High Sensitivity C-Reactive Protein for Risk Assessment; 5 Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6 Stratification of Dyslipidemic Risk; 7 Drugs for Treatment of Blood Lipoprotein Abnormalities; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; V; W; X; Z |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control |
|
|
|
|
|
|
|